(19)
(11) EP 4 569 110 A2

(12)

(88) Date of publication A3:
21.03.2024

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23755360.7

(22) Date of filing: 10.08.2023
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61P 21/00(2006.01)
A61K 31/713(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/1137; C12N 2310/14; C12N 2320/34
(86) International application number:
PCT/EP2023/072157
(87) International publication number:
WO 2024/033467 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 11.08.2022 EP 22306213

(71) Applicants:
  • Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)
  • Sorbonne Université
    75006 Paris (FR)
  • Association Institut de Myologie
    75013 Paris (FR)

(72) Inventors:
  • BITOUN, Marc
    75651 Paris Cedex 13 (FR)
  • TROCHET, Delphine
    75651 Paris Cedex 13 (FR)

(74) Representative: Inserm Transfert 
PariSanté Campus 10 rue d'Oradour-sur-Glane
75015 Paris
75015 Paris (FR)

   


(54) ALLELE SPECIFIC SIRNA THERAPY FOR DYNAMIN 2-RELATED DISEASES